USPTO 2015–2025 USPTO PatentsView US Corporation

Vactronix Scientific, LLC

USPTO PatentsView assignee record - 68 granted patents across 25 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Vactronix ranks #5,127 of 49,997 tracked US assignees by granted-patent volume, with 68 patents across 25 technology areas.

#5,127
of 49,997 US assignees by volume
Top 26%
by Innovation Score (44.4/100)
15.5
avg claims per patent
+26%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5127 · US Corporation #5,127 · 68 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 68 grants
  • UPPER-Q #5,127/49,997
  • PHOTO-FINISH emz-Hanauer & KGaA
  • CPC-FOCUS A61F · 25 areas
  • INNOV-PAR 44.4/100
  • CLAIMS-RICH 15.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +26% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: emz-Hanauer GmbH & Co. KGaA (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Vactronix

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Vactronix's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Vactronix's grants concentrate

Vactronix Scientific, LLC is a focused PatentsView assignee: 25 CPC subclasses with 77.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (14 grants) versus a trough of 4 in 2022. By volume, Vactronix sits between Umbra LLC and emz-Hanauer GmbH & Co. KGaA.

Vactronix's three-year grant acceleration

From 2019–2021 to 2022–2024, Vactronix Scientific, LLC moved from 34 to 14 grants (0.41x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Vactronix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Vactronix holds 68 patents at rank #5,126, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Vactronix

By rank, the assignees closest to #5,126 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Vactronix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vactronix, neither rank-band nor same-CPC leaders (those blocks stay above).

Vactronix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 201720182019202020212022202320242025 7
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Vactronix Scientific, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 7 10.3%
2018 6 8.8%
2019 14 20.6%
2020 13 19.1%
2021 7 10.3%
2022 4 5.9%
2023 4 5.9%
2024 6 8.8%
2025partial year 7 10.3%

Which technologies does Vactronix Scientific, LLC patent most?

Top 15 of 25 technology areas

Where it ranks

Overall rank by patents

#5,127

of 49,997 tracked assignees

Innovation Score

44.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Vactronix Scientific, LLC's patent record in context - here's where to go next.

  • Vactronix Scientific, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 77.9% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #5,127 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Vactronix Scientific, LLC against Umbra LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.